Adma Biologics, Inc.
ADMA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001368514
No open-market purchases or sales by Adma Biologics, Inc. insiders were filed in the last 90 days; 322 institutions reported holding it in 13F filings for Q2 2026, worth $1.70B in total; superinvestors Duquesne Family Office and Fundsmith hold it.
Holders of 5% or more of ADMA
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Adma Biologics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G/A | 15.10%35.9M shares | – | Apr 30, 20251 filing | Apr 30, 2025 | SEC |
| Vanguard Group Inc | 13G/A | 8.94%21.4M shares | – | Jul 29, 20251 filing | Jul 29, 2025 | SEC |
| Invesco Ltd. | 13G | 5.40%12.9M shares | +0.60 ppfrom 4.80% | Feb 7, 20252 filings | May 9, 2025 | SEC |
| State Street Corp | 13G | 5.10%12.1M shares | +0.30 ppfrom 4.80% | May 13, 20252 filings | Aug 11, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
6 Schedule 13D and 13G filings on Adma Biologics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 11, 20256:41 AM ET | State Street Corp | 13G | 5.10%12.1M shares | +0.30 ppfrom 4.80% | Jun 30, 2025 | SEC |
| Jul 29, 202511:22 AM ET | Vanguard Group Inc | 13G/A | 8.94%21.4M shares | – | Jun 30, 2025 | SEC |
| May 13, 202510:22 AM ET | State Street Corp | 13G | 4.80%11.4M shares | NewBelow 5% | Mar 31, 2025 | SEC |
| May 9, 20254:14 PM ET | Invesco Ltd. | 13G | 5.40%12.9M shares | +0.60 ppfrom 4.80% | Mar 31, 2025 | SEC |
| Apr 30, 202510:29 AM ET | BlackRock, Inc. | 13G/A | 15.10%35.9M shares | – | Mar 31, 2025 | SEC |
| Feb 7, 20251:51 PM ET | Invesco Ltd. | 13G/A | 4.80%11.3M shares | –Below 5% | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Adma Biologics, Inc. shares.
No Form 144 notices for Adma Biologics, Inc. are on file.